Catalyst Wire Dossier Catalyst Wire Dossier

TRIDESILON CREAM

Desonide 0.05% · Encore Dermatology Inc
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TRIDESILON CREAM, covering 2014-05-15 to 2016-11-02. Get the full timeline:

Most recent: FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)

See pricing